Your browser doesn't support javascript.
loading
Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells.
Harrer, Dennis Christoph; Schenkel, Charlotte; Berking, Carola; Herr, Wolfgang; Abken, Hinrich; Dörrie, Jan; Schaft, Niels.
Affiliation
  • Harrer DC; Department of Hematology and Internal Oncology, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Schenkel C; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Hartmannstraße 14, 91052 Erlangen, Germany.
  • Berking C; Leibniz Institute for Immunotherapy, Division of Genetic Immunotherapy, University Regensburg, 93053 Regensburg, Germany.
  • Herr W; Department of Dermatology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Hartmannstraße 14, 91052 Erlangen, Germany.
  • Abken H; Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg (CCC ER-EMN), Östliche Stadtmauerstraße 30, 91054 Erlangen, Germany.
  • Dörrie J; Deutsches Zentrum Immuntherapie (DZI), Ulmenweg 18, 91054 Erlangen, Germany.
  • Schaft N; Department of Hematology and Internal Oncology, University Hospital Regensburg, 93053 Regensburg, Germany.
Cancers (Basel) ; 14(20)2022 Oct 14.
Article in En | MEDLINE | ID: mdl-36291817
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Alemania Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Alemania Country of publication: Suiza